Adapalene/Benzoyl peroxide Orifarm 1 mg / g + 25 mg / g geeli Suomi - suomi - Fimea (Suomen lääkevirasto)

adapalene/benzoyl peroxide orifarm 1 mg / g + 25 mg / g geeli

orifarm healthcare a/s - benzoyl peroxide, hydrous, adapalene - geeli - 1 mg / g + 25 mg / g - adapaleeni

Imprida Euroopan unioni - suomi - EMA (European Medicines Agency)

imprida

novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - verenpainetauti - reniini-angiotensiinijärjestelmään vaikuttavat aineet - essentiaalisen hypertension hoito. imprida on tarkoitettu potilaille, joiden verenpaine ei laske riittävästi yksinomaan amlodipiinilla tai valsartaanilla.

IBUXIN 200 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuxin 200 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - ibuprofenum - tabletti, kalvopäällysteinen - 200 mg - ibuprofeeni

Ibuxin 400 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuxin 400 mg tabletti, kalvopäällysteinen

ratiopharm gmbh - ibuprofen - tabletti, kalvopäällysteinen - 400 mg - ibuprofeeni

Burana 400 mg jauhe oraaliliuosta varten, annospussi Suomi - suomi - Fimea (Suomen lääkevirasto)

burana 400 mg jauhe oraaliliuosta varten, annospussi

orion corporation - ibuprofen sodium dihydrate - jauhe oraaliliuosta varten, annospussi - 400 mg - ibuprofeeni

Ibuprofen B. Braun 600 mg infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuprofen b. braun 600 mg infuusioneste, liuos

b. braun melsungen ag - ibuprofen - infuusioneste, liuos - 600 mg - ibuprofeeni

Ibuprofen B. Braun 400 mg infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuprofen b. braun 400 mg infuusioneste, liuos

b. braun melsungen ag - ibuprofen - infuusioneste, liuos - 400 mg - ibuprofeeni

Ibuprofen B. Braun 200 mg infuusioneste, liuos Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuprofen b. braun 200 mg infuusioneste, liuos

b. braun melsungen ag - ibuprofen - infuusioneste, liuos - 200 mg - ibuprofeeni

Ibuxin 400 mg jauhe Suomi - suomi - Fimea (Suomen lääkevirasto)

ibuxin 400 mg jauhe

ratiopharm gmbh - ibuprofen - jauhe - 400 mg - ibuprofeeni

Comirnaty Euroopan unioni - suomi - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - rokotteet - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. käyttö tämä rokote tulee virallisten suositusten mukaisesti.